Global Generic Drugs Market 2014-2018 Global Generic Drugs Market 2014-2018 is the latest addition to Sandlerresearch.org industry research reports collection. To order report Call + 1 888 391 5441 or send an email on firstname.lastname@example.org with Global Generic Drugs Market 2014-2018 in subject line. Analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquisitions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market. Global Generic Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Generic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space include Actavis plc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.
Complete Report is Available @ http://www.sandlerresearch.org/global-generic-drugs-market-20142018.html .
Other vendors mentioned in the report are 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca plc, Aurobindo Pharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen Idec Inc., Boehringer Ingelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Dr. Reddyâ€™s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Gedeon Richter plc, GlaxoSmithKline plc, Hospira Inc., Impax Laboratories Inc., Intas Pharmaceuticals Ltd., Lupin Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Par Pharmaceutical Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Sanofi S.A., Wockhardt Ltd., and Zydus Cadila Healthcare Ltd. Key questions answered in this report: 1. 2. 3. 4. 5. 6. 7.
What will the market size and growth rate be in 2018? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of each of these key vendors?
Table Of Contents 01. Executive Summary 02. List of Abbreviations
Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-beforebuying?rname=15739 .
03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Category 08. Market Segmentation by Therapeutic Applications 09. Geographical Segmentation 10. Key Leading Countries The US China India 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 19.1 Actavis plc 19.2 Mylan Inc. 19.3 Novartis International AG 19.4 STADA Arzneimittel AG 19.5 Teva Pharmaceutical Industries Ltd.
20. Other Reports in this Series List of Exhibits Buy the Report @ http://www.sandlerresearch.org/purchase?rname=15739 . Request for discount on the Report @ http://www.sandlerresearch.org/discount?rname=15739 . Browse All Reports on Pharmaceutical, Therapeutics Global Generic Drugs Market 2014-2018 is the latest addition to Sandlerresearch.org industry research reports collection. To order report Call + 1 888 391 5441 or send an email on email@example.com with Global Generic Drugs Market 2014-2018 in subject line.
Published on Mar 18, 2014
Analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-sel...